Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement

JAMA Cardiology

Volumn 1, Issue 1, 2016, Pages 46-52

  Edwards, Fred H ^a   Cohen, David J ^b   O'Brien, Sean M ^c   Peterson, Eric D ^c   Mack, Michael J ^d   Shahian, David M ^e   Grover, Frederick L ^f   Tuzcu, E Murat ^g   Thourani, Vinod H ^h   Carroll, John ^f   Brennan, J Matthew ^c   Brindis, Ralph G ⁱ   Rumsfeld, John ^f   Holmes, David R ^j  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; AORTIC VALVE DISEASE; ARTICLE; CALIBRATION; CARDIOVASCULAR RISK; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; STATISTICAL MODEL; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALIDATION STUDY; COMPARATIVE STUDY; FORECASTING; HEART CATHETERIZATION; HOSPITAL PATIENT; MORTALITY; RISK; VERY ELDERLY;

AGED, 80 AND OVER; CARDIAC CATHETERIZATION; FEMALE; FORECASTING; HUMANS; INPATIENTS; MALE; MODELS, STATISTICAL; RISK; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85014498372     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2015.0326     Document Type: Article

References (29)

1. Edwards FH, Peterson ED, Coombs LP, De Long ER, Jamieson WR, Shroyer ALW, Grover FL. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001; 37(3): 885-892.
2. O'Brien SM, Shahian DM, Filardo G, et al.; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models, part 2: isolated valve surgery. Ann Thorac Surg. 2009; 88(1)(suppl):S23-S42.
3. Peterson ED, Dai D, De Long ER, et al.; NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588 398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010; 55(18):1923-1932.
4. Shahian DM, O'Brien SM, Filardo G, et al.; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models, part 3: valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009; 88(1)(suppl):S43-S62.
5. Beohar N, Whisenant B, Kirtane AJ, et al. The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. J Thorac Cardiovasc Surg. 2014; 148(6):2830-2837.e1.
6. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008; 135(1):180-187.
7. Hernández-Vaquero D, Díaz R, Morís C. Predictive risk models for transcatheter procedures: how should they be created? J Thorac Cardiovasc Surg. 2014; 148(4):1759.
8. Kötting J, Schiller W, Beckmann A, et al. German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg. 2013; 43(5):971-977.
9. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012; 59(13):1200-1254.
10. Leon MB, Smith CR, Mack M, et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-1607.
11. Makkar RR, Fontana GP, Jilaihawi H, et al.; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012; 366(18):1696-1704.
12. Smith CR, Leon MB, Mack MJ, et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23):2187-2198.
13. Durand E, Borz B, Godin M, et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol. 2013; 111(6):891-897.
14. Mack MJ. Risk scores for predicting outcomes in valvular heart disease: how useful? Curr Cardiol Rep. 2011; 13(2):107-112.
15. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011; 123(3):299-308.
16. Brown ML, Schaff HV, Sarano ME, et al. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg. 2008; 136(3):566-571.
17. Diaz R, Hernandez-Vaquero D, Llosa JC, Khalpey Z. A predictive risk model for transcatheter aortic valve procedures: an extraordinary tool but a formidable challenge. Am J Cardiol. 2013; 111(12): 1831-1832.
18. Carroll JD, Shuren J, Jensen TS, et al. Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Health Aff (Millwood). 2015; 34(2):328-334.
19. Carroll JD, Edwards FH, Marinac-Dabic D, et al. The STS-ACC Transcatheter Valve Therapy National Registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol. 2013; 62(11):1026-1034.
20. Mack MJ, Holmes DR Jr. Rational dispersion for the introduction of transcatheter valve therapy. JAMA. 2011; 306(19):2149-2150.
21. Iung B, Laouénan C, Himbert D, et al.; FRANCE 2 Investigators. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart. 2014; 100(13):1016-1023.
22. Grunkemeier GL, Jin R. Net reclassification index: measuring the incremental value of adding a new risk factor to an existing risk model. Ann Thorac Surg. 2015; 99(2):388-392.
23. Zou KH, O'Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007; 115(5):654-657.
24. Shahian DM, Edwards FH. Statistical risk modeling and outcomes analysis. Ann Thorac Surg. 2008; 86(5):1717-1720.
25. Shahian DM, Edwards FH. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: introduction. Ann Thorac Surg. 2009; 88(1) (suppl):S1.
26. Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010; 56(20): 1668-1676.
27. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014; 63(8):747-762.
28. Cleveland JC Jr. Frailty, aging, and cardiac surgery outcomes: the stopwatch tells the story. J Am Coll Cardiol. 2010; 56(20):1677-1678.
29. Lindman BR, Alexander KP, O'Gara PT, Afilalo J. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014; 7(7): 707-716.